<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01286805</url>
  </required_header>
  <id_info>
    <org_study_id>10038</org_study_id>
    <nct_id>NCT01286805</nct_id>
  </id_info>
  <brief_title>Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial</brief_title>
  <acronym>LPB Hip Scope</acronym>
  <official_title>Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New York Presbyterian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of a lumbar plexus block for
      arthroscopic hip surgery is superior to oral and intravenous opioid pain medications alone in
      treating pain. In addition, the study will examine whether lumbar plexus blocks reduce the
      total amount of pain medication needed, and therefore reduce the side effects of these
      medicines and increase patient satisfaction. It is hypothesized that addition of the lumbar
      plexus block will significantly reduce patients' postoperative pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to Discharge</measure>
    <time_frame>Day of surgery prior to discharge</time_frame>
    <description>The Numeric Rating Scale was used to ask patients to rate their pain at rest on a scale of 0 to 10, 0 = no pain and 10 = worst pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Readiness to Discharge From Post-Anesthesia Care Unit (PACU)</measure>
    <time_frame>Day of surgery prior to discharge</time_frame>
    <description>Time to readiness for discharge from the PACU. Patients were considered ready for PACU discharge when they met the following criteria: a) Awake, alert, oriented and responsive b) Minimal pain, Numeric Rating Scale &lt; 5/10 (0 = no pain, 10 = worst imaginable pain) (parenteral [injected] medications not required) c) Vital signs stable d) No active bleeding e) Minimal or no nausea f) Not vomiting, tolerating oral intake g) Oxygen saturation &gt; 94% (or baseline) on room air h) Patient has urinated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Narcotic Pain Medication Needed</measure>
    <time_frame>Day of surgery prior to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Nausea</measure>
    <time_frame>Day of surgery prior to discharge</time_frame>
    <description>The number of participants with nausea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Vomiting</measure>
    <time_frame>Day of surgery prior to discharge</time_frame>
    <description>The number of participants who vomited.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirement of Antiemetic Rescue</measure>
    <time_frame>Day of surgery prior to discharge</time_frame>
    <description>The number of participants who needed medication to treat their nausea and vomiting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>First 24 hours after surgery</time_frame>
    <description>Patient Satisfaction (0-10; 0 = very dissatisfied, 10 = very satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery (QoR-40) Physical Comfort Dimension</measure>
    <time_frame>First 24 hours after surgery</time_frame>
    <description>Assessment of Physical Comfort (minimum score = 12, maximum score = 60). Higher values represent a better outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Lumbar Plexus Blockade + CSE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group will receive a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group will receive only a combined spinal-epidural.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lumbar Plexus Blockade</intervention_name>
    <description>The lumbar plexus block will be dosed with 30 milliliters of 0.25% bupivacaine with 1:200,000 epinephrine</description>
    <arm_group_label>Lumbar Plexus Blockade + CSE</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>The control group will receive only a combined spinal-epidural.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) Class 1-3

          -  Patients aged 18 to 65 years

          -  Patients scheduled for primary, unilateral arthroscopic hip surgery by Dr. Kelly, Dr.
             Coleman, or Dr. Anil Ranawat

          -  Planned use of neuraxial anesthesia

          -  Body Mass Index less than 35

          -  Ability to follow study protocol

        Exclusion Criteria:

          -  Chronic opioid use (defined as daily or almost daily use of opioids for &gt;3 months)

          -  Contraindication to combined spinal-epidural anesthesia including but not limited to
             bleeding disorder, use of clinically relevant anticoagulant or antiplatelet
             medications, and anatomic abnormalities.

          -  Contraindication to lumbar plexus block including but not limited to bleeding
             disorder, use of clinically relevant anticoagulant or antiplatelet medications, and
             anatomic abnormalities.

          -  Infection at the injection site(s)

          -  Allergy to any of the study medications

          -  Contraindication to a short course of NSAIDs (renal failure, intolerance)

          -  ASA Class 4-5

          -  Patient refusal

          -  Patients younger than 18 years old and older than 65

          -  Patients with any known indwelling hardware of the lumbar spine.

          -  Patients with a peripheral neuropathy of the surgical extremity

          -  Non-English speaking patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques T YaDeau, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hss.edu</url>
    <description>This is the link for the Hospital for Special Surgery website</description>
  </link>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2011</study_first_submitted>
  <study_first_submitted_qc>January 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2011</study_first_posted>
  <results_first_submitted>July 23, 2012</results_first_submitted>
  <results_first_submitted_qc>May 1, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 5, 2013</results_first_posted>
  <last_update_submitted>May 1, 2013</last_update_submitted>
  <last_update_submitted_qc>May 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lumbar Plexus Blockade + CSE</title>
          <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>The control group received only a combined spinal-epidural.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lumbar Plexus Blockade + CSE</title>
          <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>The control group received only a combined spinal-epidural.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="41"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="82"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" spread="11"/>
                    <measurement group_id="B2" value="37" spread="11"/>
                    <measurement group_id="B3" value="35" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Numeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to Discharge</title>
        <description>The Numeric Rating Scale was used to ask patients to rate their pain at rest on a scale of 0 to 10, 0 = no pain and 10 = worst pain imaginable.</description>
        <time_frame>Day of surgery prior to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Numeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to Discharge</title>
          <description>The Numeric Rating Scale was used to ask patients to rate their pain at rest on a scale of 0 to 10, 0 = no pain and 10 = worst pain imaginable.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="2.2"/>
                    <measurement group_id="O2" value="4.2" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Readiness to Discharge From Post-Anesthesia Care Unit (PACU)</title>
        <description>Time to readiness for discharge from the PACU. Patients were considered ready for PACU discharge when they met the following criteria: a) Awake, alert, oriented and responsive b) Minimal pain, Numeric Rating Scale &lt; 5/10 (0 = no pain, 10 = worst imaginable pain) (parenteral [injected] medications not required) c) Vital signs stable d) No active bleeding e) Minimal or no nausea f) Not vomiting, tolerating oral intake g) Oxygen saturation &gt; 94% (or baseline) on room air h) Patient has urinated.</description>
        <time_frame>Day of surgery prior to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Readiness to Discharge From Post-Anesthesia Care Unit (PACU)</title>
          <description>Time to readiness for discharge from the PACU. Patients were considered ready for PACU discharge when they met the following criteria: a) Awake, alert, oriented and responsive b) Minimal pain, Numeric Rating Scale &lt; 5/10 (0 = no pain, 10 = worst imaginable pain) (parenteral [injected] medications not required) c) Vital signs stable d) No active bleeding e) Minimal or no nausea f) Not vomiting, tolerating oral intake g) Oxygen saturation &gt; 94% (or baseline) on room air h) Patient has urinated.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="216" spread="86"/>
                    <measurement group_id="O2" value="187" spread="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Narcotic Pain Medication Needed</title>
        <time_frame>Day of surgery prior to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Narcotic Pain Medication Needed</title>
          <units>equivalents milligrams oral morphine</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" spread="17"/>
                    <measurement group_id="O2" value="29" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Nausea</title>
        <description>The number of participants with nausea.</description>
        <time_frame>Day of surgery prior to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Nausea</title>
          <description>The number of participants with nausea.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Vomiting</title>
        <description>The number of participants who vomited.</description>
        <time_frame>Day of surgery prior to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Vomiting</title>
          <description>The number of participants who vomited.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Requirement of Antiemetic Rescue</title>
        <description>The number of participants who needed medication to treat their nausea and vomiting.</description>
        <time_frame>Day of surgery prior to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Requirement of Antiemetic Rescue</title>
          <description>The number of participants who needed medication to treat their nausea and vomiting.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>Patient Satisfaction (0-10; 0 = very dissatisfied, 10 = very satisfied)</description>
        <time_frame>First 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>Patient Satisfaction (0-10; 0 = very dissatisfied, 10 = very satisfied)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="1.6"/>
                    <measurement group_id="O2" value="7.9" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery (QoR-40) Physical Comfort Dimension</title>
        <description>Assessment of Physical Comfort (minimum score = 12, maximum score = 60). Higher values represent a better outcome</description>
        <time_frame>First 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Blockade + CSE</title>
            <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>The control group received only a combined spinal-epidural.</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery (QoR-40) Physical Comfort Dimension</title>
          <description>Assessment of Physical Comfort (minimum score = 12, maximum score = 60). Higher values represent a better outcome</description>
          <units>QoR-40 Physical Comfort score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" spread="4.3"/>
                    <measurement group_id="O2" value="52" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Lumbar Plexus Blockade + CSE</title>
          <description>The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>The control group received only a combined spinal-epidural.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Admission for nausea</sub_title>
                <description>1 control patient was admitted to the hospital for intractable nausea (attributed to opioid analgesics)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Admission for epidural spread</sub_title>
                <description>1 LPB patient was admitted for epidural spread and urinary retention (procedural complication)</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>2 LPB patients fell in the hospital bathroom without injury</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Admission for oxygen desaturation</sub_title>
                <description>1 control patient was admitted to the hospital for hypoxemia (attributed to opioid analgesics)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jacques YaDeau</name_or_title>
      <organization>Hospital for Special Surgery</organization>
      <phone>212-606-1206</phone>
      <email>yadeauj@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

